Effect of Ankaferd Blood Stopper on air leakage in the lung and prevention of bleeding: an experimental study
© Kılıçgün et al; licensee BioMed Central Ltd. 2011
Received: 21 December 2010
Accepted: 27 February 2011
Published: 27 February 2011
Air leakage and hemorrhage are important causes of morbidity and mortality in operations and traumas of the lung. Ankaferd Blood Stopper is a herbal product used for stopping hemorrhage. In our study, we investigated the efficacy of Ankaferd Blood Stopper in the prevention of air leakage in the lung and bleeding.
A total of twenty-one Wistar-Albino rats weighing 240 ± 20 grams were used in our study. An equal amount of injury was created in all groups by performing left thoracotomies. No interventions were made on tissue injury in the first group, and suturing was performed in the second group, and Ankaferd was applied in the third group. Air leakage and duration of bleeding were recorded in all groups.
A statistically significant difference was found between the three groups in terms of air leakage time (p = 0,0001) and bleeding time (p = 0,0001). While a significant effect of Ankaferd was detected in terms of air leakage compared to standard surgery (p = 0,017), no difference was found in terms of bleeding time.
Ankaferd Blood Stopper ceases the air leakage in the lung parenchyma significantly and effectively. No significant difference is seen compared to the standard surgery group, although it ceases bleeding significantly.
Prolongation of air leakage and bleeding after lung operations are among the important causes of morbidity. Prolongation of air leakage is the second leading cause of delay in the time of discharge from the hospital . Prolonged parenchymal air leakage is commonly seen after lung resections and has been reported at a rate of 15-18%. Thus, chest tubes are needed for a longer time and consequently, this causes pain, decreased mobility and possible complications . The standard method for prevention of air leakage and bleeding developing following lung resection is surgical suturing or stapler application. Tissue adhesives and supported stapler use are the other methods [3–10].
Ankaferd Blood Stopper (ABS) is a herbal product used as a hemostatic agent in traditional Turkish medicine. It is a topical agent, the safety and efficacy of which have been proven in dermal, external traumatic, postoperative and dental bleedings . Clinical and experimental studies on its blood stopping effect are available. Its effect on stopping bleeding and preventing air leakage in the lungs is not known. In this study, we experimentally investigated the effect of Ankaferd Blood Stopper on stopping bleeding and preventing air leakage in the lungs.
This study was carried out in the animal experiment laboratory of our institution. All rats were treated in a humane manner according to the Guide for the Care and Use of Laboratory Animals. The study was commenced after having obtained approval from the ethical committee for experimental animals.
A total of 21 adult male Wistar Albino rats weighing 240 ± 20 grams were used in our study. Three groups were constituted with seven rats in each. An equal extent of injury was created in all groups by performing left thoracotomies. No interventions were made on the tissue injury in the first group (control group), suturing was performed in the second group (standard surgery group), and Ankaferd Blood Stopper was applied in the third group (Ankaferd group). Air leakage and duration of bleeding were recorded in all groups. The rats were sacrificed after the procedure had been completed and histopathological assessment was performed.
General anesthesia was applied on all test subjects. A combination of 60 mg/kg ketamin hydrochloride (Ketalar, Parke Davis-Eczacıbası, İstanbul, Turkey) and 10 mg/kg xylacine hydrochloride (Rompun, Bayer, Toronto, Canada) were used as anesthetic agents. The rats were fixed in the supine position. The operation sites were cleaned and sterilization was provided. Tracheotomies were performed with neck incisions and intubation was performed.
All the rats underwent left anterior thoracotomy. An injury 5 mm in length and 2mm in depth was created in the left lung parenchyma using a scalpel. In the control group (Group I), no interventions were made for parenchymal injury and a compress was applied and continuation of the air leakage and bleeding was monitored every 5 seconds. These durations were recorded. The procedure was terminated at the 100. second. In the standard surgery group (Group II), after having created an equal injury, the injury was sutured using 6-0 polyglactin (vicryl). Then the air leakage and bleeding were controlled and the times of cessation of the leakage and bleeding were recorded. In the Ankaferd group (Group III), a spray form of the Ankaferd Blood Stopper was applied 4 times onto the identical injury. It was controlled at every 5 seconds and cessation times of the air leakage and bleeding were recorded.
All statistical analyses and calculations were performed using the SPSS for Windows Version 16.0 (SPSS Inc, Chicogo, IL, USA) package program. The Kruskal Wallis test was used to find whether or not there was a difference between the three groups in terms of air leakage time and bleeding time. Paired assessments were made using the Mann Whitney U test to find the group where the difference originated from. The level of significance was set at p < 0.05.
Some of the rats (n = 11) were sacrificed intraoperatively after the procedure had been completed and the specimens were obtained from the lung. The remaining rats (n = 10) were sacrificed after monitorization for five days and the lung was analyzed patologically on the fifth day. The sampled lung tissue was fixed with formalin solution (10%). Paraffin cross sections were obtained after routine follow-up and analyzed after staining with hematoxylin-eosin.
Mean air leakage and bleeding times of the groups
Mean air leakage time (sec)
Mean bleeding time (sec)
Group I (control group)
95.7 ± 6.07
75.00 ± 15.00
Group II (standard surgery group)
27.14 ± 21.76
9.28 ± 7.31
Group III (Ankaferd group)
7.14 ± 2.67
7.14 ± 2.68
A statistically significant difference was found between the three groups in terms of duration of air leakage (p = 0,0001) and bleeding (p = 0,001). There was a statistically significant difference between the control group and the standard surgery group in terms of duration of leakage (p = 0,002) and bleeding time (p = 0,001). A statistically significant difference was found between the standard surgery group and the Ankaferd group in terms of air leakage (p = 0,017). No statistically significant difference was found between the standard surgery group and the Ankaferd group in terms of bleeding time (p = 0,827). A statistically significant difference was detected between the control group and the Ankaferd group in terms of air leakage time (p = 0,001) and bleeding time (p = 0,001).
The incidence of leakage from the lung parenchyma is still vey high despite the use of many surgical techniques and biological agents to reduce it. Leakage is observed at a rate between 48% and 70% intraoperatively, and the rate of air leakages continuing for longer than the 7. postoperative day is between 15% and 18%. The ideal method for preventing this has yet not been determined .
Prolongation of air leakage is the second leading cause of delay in the time of discharge from the hospital following pain . Prolongation of air leakage following lung resections is among the important causes of morbidity. It is the second leading complication following arrhythmias. Cause of morbidity is air leakage exceeding five days after segmentectomy (5.9%), lobectomy (9.6%) and pneumectomy (0.4%) . In the study of Varela et al.  air leakage exceeding five days was found to be related to significant pulmonary complications and atelectasis, pneumonia, and empyema.
Air lekage is a common condition seen after lung operations. The standard method for prevention of air leakages developing following lung operations is surgical suturing or stapler application. The other methods are fibrin glue, synthetic polyethylene glucose-based hydrogel adhesives, tachocomb, covered adhesives or stapler use supported with various materials [3–10].
Fibrin glue application is a commonly used approach. There are different opinions about the utilization of fibrin glue. In the prospective study carried out by Fabian et al.  fibrin glue was applied to one group in 100 lung resections. Both groups were compared in terms of air leakage, amount of pleural drainage, time of chest tube removal and duration of hospitalization. Utilization of fibrin glue was shown to significantly decrease the incidence of air leakage, the air leakage cessation time, chest tube removal time, and the rate of prolonged air leakage. No difference was found in terms of the amount of chest tube drainage and duration of hospitalization. No complications related to fibrin glue were found. In conclusion, fibrin glue utilization was reported to be effective and safe. In a study carried out with fibrin glue comprising 360 patients, it was shown to decrease only the chest tube removal time and not to affect the prolongation of air leakage (>7 days) and duration of hospitalization .
Ankaferd Blood Stopper (ABS) is a herbal product used as a hemostatic agent. It contains a standardized mixture of Thymus vulgaris, Glycyrrhiza glabra, Vitis vinifera, Alpinia officinarum and Urtica dioica. All of these plants are effective on the endothelium, blood cells, angiogenesis, cellular proliferation, vascular dynamics and mediators. The mechanism of action of this drug which is being used clinically and found to be safe is not fully understood . There have been no studies investigating the effect of Ankaferd Blood Stopper on air leakage in the lung. In our study, we investigated the air leakage repressive effect of ABS. It prevents air leakage significantly compared to the control group and the standard surgery group.
Postoperative hemorrhage is among the important causes of morbidity in thoracic surgery practice. The incidence of at least 4 units of blood transfusion requirement after lung resections is 2.9% in lobectomy, 3% in pneumonectomy . The focus of hemorrhage cannot be determined in most of the cases. In the study of Sirbu et al. analyzing 1960 patients who underwent thoracotomy, they detected that the most common cause of re-thoracotomy was bleeding (52%). In this study, while the source of bleeding was found to be mediastinal and bronchial vessels (23%), intercostal vessels (17%) or pulmonary vessels (17%), no sources of bleeding could be detected in most of the cases (41%) .
The blood stopping effect of Ankaferd Blood Stopper has been demonstrated in many clinical and experimental studies. It was found to be successful in the treatment of rectal ulcers in the study of Ibis et al.  which was carried out in gastrointestinal hemorrhages. It was shown to reduce hemorrhage considerably in bladder hemorrhages and partial nephrectomies . Ankaferd Blood Stopper was shown to decrease the operation time and warm ischemia time in the partial nephrectomy model in rats. In the pathological anaysis, erythrocyte aggregation was found to develop, but glomerular necrosis and calcifications were not observed . ABS was reported to reduce hemorrhage effectively in the study on its clinical use in tonsillectomies . It was emphasized that it could be beneficial clinically when used endoscopically in gastrointestinal hemorrhages related to tumor . Similarly, it was stated to be effective in hemorrhages related to endobronchial tumor when used endoscopically .
In our study, when we evaluated the blood stopping effect of ABS, we found that this property was prominent compared to the control group; however, there was no statistically significant difference compared to the standard surgery group. Ankaferd Blood Stopper prevents air leakage in the lung effectively. It has an effect on stopping bleeding, but the effect is similar to that in standard surgery. Further experimental and clinical studies are needed to investigate the effect of this plant extract in the lung.
- Shaw JP, Locicero J: Postoperative management of the general thoracic surgical patient. General Thoracic Surgery. Edited by: Shields TW, Locicero III J, Reed CE, Feins RH. 2009, Philadelphia: Lippincott Williams and Wilkins, 571-579. 7Google Scholar
- D'Andrilli A, Andreetti C, Ibrahim M, Ciccone AM, Venuta F, Mansmann U, Rendina EA: A prospective randomized study to assess the efficacy of a surgical sealant to treat air leaks in lung surgery. Eur J Cardiothorac Surg. 2009, 35: 817-820.View ArticlePubMedGoogle Scholar
- Lang G, Csekeö A, Stamatis G, Lampl L, Hagman L, Marta GM, Mueller MR, Klepetko W: Efficacy and safety of topical application of human fibrinogen/thrombin-coated collagen patch (TachoComb) for treatment of air leakage after standart lobectomy. Eur J Cardiothorac Surg. 2004, 25: 160-166. 10.1016/j.ejcts.2003.11.018.View ArticlePubMedGoogle Scholar
- Fabian T, Federico JA, Ponn RB: Fibrin glue in pulmonary resection: prospective, randomized, blinded study. Ann Thorac Surg. 2003, 75: 1587-1592. 10.1016/S0003-4975(02)04994-9.View ArticlePubMedGoogle Scholar
- Gagarine A, Urschell JD, Miller JD, Bennett WF, Young JE: Effect of fibrin glue on air leak and length of hospital stay after pulmonary lobectomy. J Cardiovasc Surg (Torino). 2003, 44: 771-773.Google Scholar
- Macchiarini P, Wain J, Almy S, Dartevelle P: Experimental and clinical evaluation of a new synthetic, absorbable sealant to reduce air leaks in thoracic operations. J Thorac Cardiovasc Surg. 1999, 117: 751-758. 10.1016/S0022-5223(99)70296-5.View ArticlePubMedGoogle Scholar
- Yamato Y, Eguchi S, Terashima M, Koike T, Kobayashi K, Kawamura M, Kato H, Kawate N, Hitomi S, Mizuro H, Ogawa N: Closing effect of a sheet-form fibrin adhesive (TO-193) and a fibrin adhesive on air leakage in pulmonary surgery: a comparative study. Geka Shinryo. 1995, 37: 245-254.Google Scholar
- Vaughn CC, Vaughn PL, Vaughn CC, Sawyer P, Manning M, Anderson D, Roseman L, Herbst TJ: Tissue response to biomaterials used for staple-line reinforcement in lung resection: a comparison between expanded polytetrafluoroethylene and bovine pericardium. Eur J Cardiothorac Surg. 1998, 13: 259-265. 10.1016/S1010-7940(98)00012-8.View ArticlePubMedGoogle Scholar
- Stammberger U, Klepetko W, Stamatis G, Hamacher J, Schmid RA, Wisser W, Hillerjan L, Weder W: Buttressing the staple line in lung volume reduction surgery: a randomized three-center study. Ann Thorac Surg. 2000, 70: 1820-1825. 10.1016/S0003-4975(00)01903-2.View ArticlePubMedGoogle Scholar
- Miller JI, Landreneau RJ, Wright CE, Santucci TS, Sammons BH: A comparative study of buttressed versus nonbuttressed staple line in pulmonary resections. Ann Thorac Surg. 2001, 71: 319-322. 10.1016/S0003-4975(00)02203-7.View ArticlePubMedGoogle Scholar
- Haithcock BE, Feins RH: Complications of Pulmonary Resection. General Thoracic Surgery. Edited by: Shields TW, Locicero III J, Reed CE, Feins RH. 2009, Philadelphia: Lippincott Williams and Wilkins, 551-559. 7Google Scholar
- Varela G, Jimenez MF, Novoa N, Aranda JL: Estimating hospital costs attributable to prolonged air leak in pulmonary lobectomy. Eur J Cardiothorac Surg. 2005, 27: 329-333. 10.1016/j.ejcts.2004.11.005.View ArticlePubMedGoogle Scholar
- Goker H, Haznedaroglu IC, Ercetin S, Kirazli S, Akman U, Ozturk Y, Firat HC: Haemostatic actions of the folkloric medicinal plant extract ankaferd blood stopper. J Int Med Res. 2008, 36: 163-170.View ArticlePubMedGoogle Scholar
- Sirbu H, Busch T, Aleksic I, Lotfi S, Ruschewski W, Dalichau H: Chest re-exploration for complications after lung surgery. Thorac Cardiovasc Surg. 1999, 47: 73-76. 10.1055/s-2007-1013114.View ArticlePubMedGoogle Scholar
- Ibis M, Kurt M, Onal IK, Haznedaroglu IC: Successful management of bleeding due to solitary rectal ulcer via topical application of Ankaferd blood stopper. J Altern Complement Med. 2008, 14: 1073-1074. 10.1089/acm.2008.0314.View ArticlePubMedGoogle Scholar
- Huri E, Akgül T, Ayyıldız A, Ustün H, Germiyanoglu C: Hemostatic role of a folkloric medicinal plant extract in a rat partial nephrectomy model: controlled experimental trial. J Urol. 2009, 181: 2349-2354. 10.1016/j.juro.2009.01.016.View ArticlePubMedGoogle Scholar
- Teker AM, Korkut AY, Gedikli O, Kahya V: Prospective, controlled clinical trial of Ankaferd Blood Stopper in children undergoing tonsillectomy. Int J Pediatr Otorhinolaryngol. 2009, 73: 1742-1745. 10.1016/j.ijporl.2009.09.029.View ArticlePubMedGoogle Scholar
- Kurt M, Akdoğan M, Onal IK, Kekilli M, Arhan M, Shorbagi A, Aksu S, Kurt OK, Haznedaroglu IC: Endoscopic topical application of Ankaferd Blood Stopper for neoplastic gastrointestinal bleeding: A retrospective analysis. Dig Liver Dis. 2010, 42: 196-199. 10.1016/j.dld.2009.05.006.View ArticlePubMedGoogle Scholar
- Arslan S, Haznedaroglu CI, Öz B, Goker H: Endobronchial application of Ankaferd blood stopper to control profuse lung bleeding leading to hypoxemia and hemodynamic instability. Respiratory Medicine CME. 2009, 2: 144-146. 10.1016/j.rmedc.2008.10.016.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.